Overview
Tomohide Sugiyama practices in Utsunomiya, Japan. Sugiyama is highly rated in 4 conditions, according to our data. Their top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
Their clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerSugiyama isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung CancerSugiyama isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)Sugiyama isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- AgranulocytosisSugiyama isExperienced. Learn about Agranulocytosis.
- ParonychiaSugiyama isExperienced. Learn about Paronychia.
- ThrombocytopeniaSugiyama isExperienced. Learn about Thrombocytopenia.
- Thymic Epithelial TumorSugiyama isExperienced. Learn about Thymic Epithelial Tumor.